Proteins Sponsors 2013
- Aldevron
Aldevron provides contract manufacturing and scientific services. We specialise in antibody generation, protein and plasmid DNA production. As a customer-oriented service provider, Aldevron’s team helps to guide and advise its clients through intensive interaction, in order to find optimal solutions to their individual needs.
- Applied Photophysics Ltd
Applied Photophysics Ltd. (APL) has firmly established itself as a global developer and manufacturer of high quality, high performance, modern spectrometers for the study of structural, thermodynamic and kinetic properties of a wide range of samples with particular focus on proteins and other bio-macromolecules.
- BLIRT
BLIRT, established in 2008, is a leading CEE biotechnology company focused on contract research services and in-house R&D Projects (oncology and antifungal). As a high quality and customer-oriented company, BLIRT provides a broad-range portfolio of services to support development of new drugs, focusing on proteins and antibodies.
- Charles River
CHARLES RIVER, provides solutions that advance the drug discovery and development process. Our leading-edge products and services enable our clients to bring drugs to market faster and more efficiently. 7,000 employees serve clients in more than 50 countries over America, Europe and Asia.
- DNA2.0
DNA2.0 is the leading bioengineering solutions provider. Founded in 2003, DNA2.0 provides an integrated pipeline of solutions for the research community, including gene design, optimization, synthesis and cloning, as well as platforms for protein and strain engineering. It is the fastest provider of synthetic genes—based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries.
- Eurogentec
Eurogentec, part of Kaneka Corporation, was founded in 1985 as a spin-off from the University of Liège (Belgium) and it is headquartered in the LIEGE Science Park. Through its three Business Units, Eurogentec is a leading global supplier of trusted and Innovative Solutions to the Life Science Communities.
- ForteBio
ForteBio - A Division of Pall Life Sciences markets the Octet and BLItz platforms for label-free, high-throughput and micro-volume analysis. The platforms include instruments, 15 biosensor chemistries, and software to measure affinity, kinetics, and concentration in crude or purified samples. These real-time, “dip and read” methods allow simpler, faster and more cost-effective workflows compared to SPR, ELISA and HPLC.
- GTP Technology
GTP Technology is a CRO with over 10 years experience providing customized gene-to-protein services to help scientists concentrate on their core activities. We offer production of recombinant proteins in bacterial, yeast, insect and mammalian systems, at up to hundred grams scale. Our clients range from international companies to start-ups in many sectors: pharmaceutical, biotech, food, diagnostic, veterinary. Our mission is to handle their protein challenges as if we were their own internal provider: we offer a high level of flexibility, open communication, responsiveness and confidentiality.
- Nanosight
NanoSight delivers the world’s most versatile and proven multi-parameter nanoparticle analysis in a single instrument. NanoSight has installed over 550 systems worldwide with users including GlaxoSmithKline, Merck, Novartis, Pfizer, Proctor and Gamble, and Roche, together with the most eminent universities and research institutes. NanoSight’s technology is validated by 600+ third party papers citing NanoSight results and by the ASTM Standard E2834, consolidating NanoSight’s leadership position in nanoparticle characterisation.
- PerkinElmer
PerkinElmer offers solutions to ensure the consistent, reproducible results of your biotherapeutics research and patient safety considerations demand. GLP-compliant processes in the world’s leading pharmaceutical, biotechnology and contract research organizations include our portfolio of assays, instrumentation, informatics and technical expertise across the biotherapeutics workflow.
- PhyNexus
Founded in 2002 on the philosophy of applying analytical principles to biological problems, PhyNexus has developed a unique technology that improves and accelerates the drug discovery and drug development processes.
- PolyTherics
PolyTherics is a UK biotech company providing technology solutions enabling development of better biopharmaceuticals. PolyTherics and Biotecnol (for the development of Tribody™ - drug conjugates ) offers proprietary site-specific conjugation technologies for half-life extension of protein therapeutics, the creation of bispecific products and the efficient production of stable, homogeneous antibody-drug conjugates, including antibody fragment-drug conjugates. PolyTherics partners include Nuron Biotech (TheraPEG™ interferon β), Celtic Pharma Holdings/Pro Bono Bio (TheraPEG™ variants of Factor VIIA and Factor IX) and Spirogen (for the development of novel ADC reagents).
- ProteinSimple
ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. The Company's strategy is to power protein research by making it simpler and more quantitative, ultimately revealing new insights into the true nature of proteins. ProteinSimple has built a unique portfolio of protein analysis tools including systems for traditional protein imaging, systems to probe the structure and purity of protein based therapeutics and systems that provide fresh insight into protein signaling.
- Quality Assistance
As a leading European Contract Research Organisation, Quality Assistance provides (bio)pharmaceutical companies with comprehensive analytical services. Quality Assistance holds a unique position on the market thanks to its 31 years’ experience, 115 highly-qualified professionals and 6 laboratories on one site covering all the analytical technologies needed to support your drug development.
- Retrogenix
Retrogenix has developed a world-leading technology for discovering which human plasma membrane proteins are targeted by antibodies, proteins, small molecules and viruses. Retrogenix is a privately owned biotechnology company founded in 2008, and is based in the Peak District National Park, UK.
